Cross-Sector entity
Pharmaceuticals Export Promotion Council of India (Pharmexcil) is most often covered alongside Bulk drugs and drug intermediates, which appears in 2 of these 2 stories. The clearest coverage concentration is economy: 1 of 2 stories, with the rest divided among 1 other category.
2 verified stories tracked
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Pharmaceuticals Export Promotion Council of India (Pharmexcil) is most often covered alongside Bulk drugs and drug intermediates, which appears in 2 of these 2 stories. The clearest coverage concentration is economy: 1 of 2 stories, with the rest divided among 1 other category. The tracked stories average 2 original sources each. Pharmaceuticals Export Promotion Council of India (Pharmexcil) appears in 2 tracked Cross-Sector stories from August 12, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Pharmaceuticals Export Promotion Council of India (Pharmexcil). Shared-story counts are live from our verified record — not editorial picks.
India's pharma exports grew 6.8% to $8.1B in Q1 FY27, with the US absorbing $2.5B at a 30.89% share — trade and earnings data that shapes the outlook for Indian healthcare exporters and investors.
India's vaccine exports jumped 35.68% to $390M in Q1 FY27 amid $8.1B in total pharma shipments, strengthening the country's role as a supplier of affordable vaccines and generics to global health systems.
Source: moneycontrol.com · calcuttanews.net
